Is Sanofi A Buy, Despite Recent Stumbles? - Rickey J. White, Jr. | RJW™
27976
post-template-default,single,single-post,postid-27976,single-format-standard,bridge-core-3.3.2,qode-optimizer-1.0.3,qode-page-transition-enabled,ajax_fade,page_not_loaded,,qode-theme-ver-30.8.3,qode-theme-bridge,qode_header_in_grid,wpb-js-composer js-comp-ver-8.0,vc_responsive
 

Is Sanofi A Buy, Despite Recent Stumbles?

19 Aug Is Sanofi A Buy, Despite Recent Stumbles?

Posted at 05:00h in Popular Newsfeed by
0 Likes

Pharmaceuticals are subject to whiplash trade. That’s evident with sharp moves lower in Sanofi, GSK and Teva on news about clinical trials and legal actions.
Source: Entrepreneur.com Lastest News

Tags:
No Comments

Sorry, the comment form is closed at this time.